| 國立成功大學 |
2024-08 |
Agalactosyl IgG induces liver fibrogenesis via Fc gamma receptor 3a on human hepatic stellate cells
|
Ho;Cheng-Hsun;Chang;Ting-Tsung;Lin;Hsien-Chang;Wang;Sheng-Fan |
| 國立成功大學 |
2024-07 |
Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients
|
Yuen;Man-Fung;Chuang;Wan-Long;Peng;Cheng-Yuan;Jeng;Wen-Juei;Su;Wei-Wen;Chang;Ting-Tsung;Chen;Chi-Yi;Hsu;Yao-Chun;Rosa, De La;Guy;Ahmad;Alaa;Luo;Ed;Conery;Annie, L. |
| 國立成功大學 |
2023-07-10 |
The B56γ3-containing protein phosphatase 2A attenuates p70S6K-mediated negative feedback loop to enhance AKT-facilitated epithelial-mesenchymal transition in colorectal cancer
|
Hsiao;Kai-Ching;Ruan;Siou-Ying;Chen;Shih-Min;Lai;Tai-Yu;Chan;Ren-Hao;Zhang;Yan-Ming;Chu;Chien-An;Cheng;Hung-Chi;Tsai;Hung-Wen;Tu;Yi-Fang;Law;Brian, K.;Chang;Ting-Tsung;Chow;Nan-Haw;Chiang;Chi-Wu |
| 國立成功大學 |
2023-04-29 |
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan
|
Wu;Juei-Seng;Lin;Yih-Jyh;Chang;Ting-Tsung;Wang;Chung-Teng;Liu;Wen-Chun;Hsieh;Ming-Tsung;Wu;I-Chin;Chen;Po-Jun;Chen;Chiung-Yu;Lin;Sheng-Hsiang;Chuang;Chiao-Hsiung;Han;Meng-Zhi;Chen;Huang-Pin;Tsai;Hong-Ming;Kuo;Hsin-Yu |
| 國立成功大學 |
2023-02 |
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
|
Chiang;Hsueh-Chien;Lee;Yang-Cheng;Chang;Ting-Tsung;Lin;Yih-Jyh;Wu;Hung-Tsung;Wang;Chung-Teng;Chen;Chiung-Yu;Chen;Po-Jun;Hsieh;Ming-Tsung;Lin;Sheng-Hsiang;Chen;Shang-Hung;Chuang;Chiao-Hsiung;Wu;I-Chin;Hong;Tzu-Chun;Wu;Juei-Seng;Han;Meng-Zhi;Chen;Wei-Ting;Chiang;Chien-Ming;Hung;Kuan-Kai;Kuo;Hsin-Yu |
| 國立成功大學 |
2022-11 |
Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
|
Kuo;Hsin-Yu;Han;Meng-Zhi;Liao;Chih-Hsiang;Lin;Yih-Jyh;Wang;Chung-Teng;Chen;Shang-Hung;Chang;Ting-Tsung;Chen;Po-Jun;Lin;Sheng-Hsiang;Chen;Chiung-Yu;Chuang;Chiao-Hsiung;Wu;I-Chin;Wu;Juei-Seng;Hong;Tzu-Chun;Hsieh;Ming-Tsung;Lee;Yang-Cheng;Wu;Hung-Tsung;Tsai;Hong-Ming |
| 國立成功大學 |
2022-08 |
The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients
|
Tseng;Chih-Wei;Liu;Wen-Chun;Ko;Ping-Hung;Chen;Yen-Chun;Tseng;Kuo-Chih;Chang;Ting-Tsung |
| 國立成功大學 |
2021-08 |
Detection of CTNNB1 Hotspot Mutations in Cell-Free DNA from the Urine of Hepatocellular Carcinoma Patients
|
Lin;Selena, Y.;Chang;Ting-Tsung;Steffen;Jamin, D.;Chen;Sitong;Jain;Surbhi;Song;Wei;Lin;Yih-Jyh;Su;Ying-Hsiu |
| 國立成功大學 |
2021-07 |
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
|
Tsai;Hong-Ming;Han;Meng-Zhi;Lin;Yih-Jyh;Chang;Ting-Tsung;Chen;Chiung-Yu;Cheng;Pin-Nan;Chuang;Chiao-Hsiung;Wu;I-Chin;Chen;Po-Jun;Kang;Jui-Wen;Chiu;Yen-Cheng;Chiu;Hung-Chih;Chien;Shih-Chieh;Kuo;Hsin-Yu |
| 國立成功大學 |
2021-06 |
Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss
|
Wu;I-Chin;Liu;Wen-Chun;Chiu;Yen-Cheng;Chiu;Hung-Chih;Cheng;Pin-Nan;Chang;Ting-Tsung |
| 國立成功大學 |
2021-03 |
Effectiveness and safety of ledipasvir/ sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan
|
Chiu;Hung-Chih;Chiu;Yen-Cheng;Yang;Er-Hsiang;Chang;Ting-Tsung;Chien;Shih-Chieh;Wu;I-Chin;Wu;Chun-Hsien;Cheng;Pin-Nan |
| 國立成功大學 |
2020-05 |
Impact of Immune Checkpoint Inhibitors with or without a Combination of Tyrosine Kinase Inhibitors on Organ-Specific Efficacy and Macrovascular Invasion in Advanced Hepatocellular Carcinoma
|
Kuo;Hsin-Yu;Chiang;Nai-Jung;Chuang;Chiao-Hsiung;Chen;Chiung-Yu;Wu;I-Chin;Chang;Ting-Tsung;Tsai;Hong-Ming;Lin;Yih-Jyh |
| 國立成功大學 |
2020-04 |
Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patients
|
Liu;Wen-Chun;Wu;I-Chin;Chiu;Yen-Cheng;Tseng;Kuo-Chih;Chen;Chi-Yi;Chiu;Hung-Chih;Cheng;Pin-Nan;Chang;Ting-Tsung |
| 國立成功大學 |
2019-11 |
Insulin Resistance Associated Disorders Pivoting Long-Term Hepatitis B Surface Antigen Decline During Entecavir Therapy
|
Lin;Tien-Ching;Liu;Wen-Chun;Hsu;Yu-Hsiang;Lin;Jia-Jhen;Chiu;Yen-Cheng;Chiu;Hung-Chih;Cheng;Pin-Nan;Chen;Chiung-Yu;Chang;Ting-Tsung;Wu;I-Chin |
| 國立成功大學 |
2019-10 |
Contrast-Induced Acute Kidney Injury Among Patients With Chronic Kidney Disease Undergoing Imaging Studies: A Meta-Analysis
|
Lee;Yen-Chien;Hsieh;Chung-Cheng;Chang;Ting-Tsung;Li;Chung-Yi |
| 國立成功大學 |
2019-03 |
Fully galactosyl-fucosyl-bisected IgG(1) reduces anti-HBV efficacy and liver histological improvement
|
Ho;Cheng-Hsun;Chen;Shu-Hui;Tsai;Hung-Wen;Wu;I-Chin;Chang;Ting-Tsung |
| 國立成功大學 |
2019 |
Combined Transarterial Embolization/Chemoembolization-Based Locoregional Treatment with Sorafenib Prolongs the Survival in Patients with Advanced Hepatocellular Carcinoma and Preserved Liver Function: A Propensity Score Matching Study
|
Chien;Shih-Chieh;Chen;Chiung-Yu;Cheng;Pin-Nan;Liu;Yi-Shan;Cheng;Hsiu-Chi;Chuang;Chiao-Hsiung;Chang;Ting-Tsung;Chiu;Hong-Chi;Lin;Yih-Jyh;Chiu;Yen-Cheng |
| 國立成功大學 |
2018-08 |
Viral dynamics of persistent hepatitis C virus infection in high-sensitive reporter cells resemble patient's viremia
|
Tsai;Peiju;Lin;Chun-Chieh;Sun;Hung-Yu;Lee;Jin-Ching;Chang;Ting-Tsung;Young;Kung-Chia |
| 國立成功大學 |
2018-06-2 |
Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations
|
Wu;I-Chin;Liu;Wen-Chun;Chang;Ting-Tsung |
| 國立成功大學 |
2018-03-14 |
Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma
|
Tsai;Hung-Wen;Ho;Chung-Liang;Cheng;Shu-Wen;Lin;Yih-Jyh;Chen;Chou-Cheng;Cheng;Pin-Nan;Yen;Chia-Jui;Chang;Ting-Tsung;Chiang;Po-Min;Chan;Shih-Huang;Ho;Cheng-Hsun;Chen;Shu-Hui;Wang;Yi-Wen;Chow;Nan-Haw;Lin;Jou-Chun |
| 國立成功大學 |
2018-02-14 |
Clinical utility of hepatitis B surface antigen kinetics in treatment-naive chronic hepatitis B patients during long-term entecavir therapy
|
Lin;Tien-Ching;Chiu;Yen-Cheng;Chiu;Hung-Chih;Liu;Wen-Chun;Cheng;Pin-Nan;Chen;Chiung-Yu;Chang;Ting-Tsung;Wu;I-Chin |
| 國立成功大學 |
2017-10 |
Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virus
|
Liu;Wen-Chun;Wu;I-Chin;Lee;Yen-Chien;Lin;Chih-Peng;Cheng;Ji-Hong;Lin;Yih-Jyh;Yen;Chia-Jui;Cheng;Pin-Nan;Li;Pei-Fu;Cheng;Yi-Ting;Cheng;Pei-Wen;Sun;Koun-Tem;Yan;Shu-Ling;Lin;Jia-Jhen;Yang;Jui-Chu;Chang;Kung-Chao;Ho;Cheng-Hsun;Tseng;Vincent, S.;Chang;Bill, Chia-Han;Wu;Jaw-Ching;Chang;Ting-Tsung |
| 國立成功大學 |
2017-05-16 |
Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg- positive Patients with High Serum Fucosyl- Agalactosyl IgG
|
Ho;Cheng-Hsun;Tsai;Hung-Wen;Lee;Chen-Yeh;Huang;Li-Juan;Chien;Rong-Nan;Wu;I-Chin;Chiu;Yen-Cheng;Liu;Wen-Chun;Cheng;Pin-Nan;Chang;Ting-Tsung;Chen;Shu-Hui |
